Related Experiment Video
Updated: Jan 26, 2026

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
Published on: June 8, 2020
Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6*I on ROS metabolism
Philippe Paget-Bailly1,2, Koceila Meznad1,2, Diane Bruyère3
1EA3181, LabEx LipSTIC ANR-11-LABX-0021, UFR Santé, 19 rue Ambroise Paré, Besançon, France.
Abstract:
High-risk Human Papillomavirus infections are responsible for anogenital and oropharyngeal cancers. Alternative splicing is an important mechanism controlling HPV16 gene expression. Modulation in the splice pattern leads to polycistronic HPV16 early transcripts encoding a full length E6 oncoprotein or truncated E6 proteins, commonly named E6*. Spliced E6*I transcripts are the most abundant RNAs produced in HPV-related cancers. To date, the biological function of the E6*I isoform remains controversial. In this study, we identified, by RNA sequencing, cellular targets deregulated by E6*I, among which genes related to ROS metabolism. Concomitantly, E6*I-overexpressing cells display high levels of ROS. However, co-overexpression of both E6 and E6*I has no effect on ROS production. In HPV16-infected cells expressing different E6/E6*I levels, we show that the newly identified targets CCL2 and RAC2 are increased by E6*I but decreased by E6 expression, suggesting that E6 abrogates the effect of E6*I. Taken together, these data support the idea that E6*I acts independently of E6 to increase ROS production and that E6 has the ability to counteract the effects of E6*I. This asks the question of how E6*I can be considered separately of E6 in the natural history of HPV16 infection.
Insights
The Human Papillomavirus E6*I protein increases reactive oxygen species (ROS) independently of the E6 protein. E6 can counteract E6*I
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- High-risk Human Papillomavirus (HPV) infections cause anogenital and oropharyngeal cancers.
- Alternative splicing of HPV16 transcripts generates E6 and truncated E6* isoforms, with E6*I being abundant in HPV-related cancers.
- The specific function of the E6*I isoform remains unclear.
Purpose of the Study:
- To investigate the biological function of the HPV16 E6*I isoform.
- To identify cellular targets regulated by E6*I.
- To determine the interplay between E6 and E6*I in regulating cellular processes like ROS metabolism.
Main Methods:
- RNA sequencing to identify cellular targets deregulated by E6*I.
- Cell culture models overexpressing E6 and/or E6*I.
- Measurement of reactive oxygen species (ROS) levels.
- Analysis of specific gene expression (CCL2, RAC2).
Main Results:
- E6*I overexpression leads to increased ROS levels.
- E6*I deregulates genes involved in ROS metabolism, including CCL2 and RAC2.
- E6 expression counteracts the effects of E6*I on ROS production and target gene expression.
- Co-overexpression of E6 and E6*I does not affect ROS production.
Conclusions:
- E6*I acts independently of E6 to increase ROS production.
- E6 can abrogate the effects of E6*I, suggesting a complex regulatory relationship.
- The independent function of E6*I warrants further investigation in HPV16 pathogenesis.
Related Concept Videos
What is Metabolism?
RNA Stability
RNA Splicing
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Editing
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...

